These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 20146168)

  • 41. THE IMPACT OF 12-MONTH GROWTH HORMONE REPLACEMENT THERAPY ON LIPID METABOLISM AND ADIPOSE TISSUE DISTRIBUTION IN GEORGIAN PATIENTS WITH ADULT GROWTH HORMONE DEFICIENCY.
    Bostoganashvili N; Zerekidze T; Janjgava S; Lomidze M
    Georgian Med News; 2017 Dec; (273):36-41. PubMed ID: 29328027
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Reduction in insulin sensitivity and inadequate β-cell capacity to counteract the increase in insulin resistance in children with idiopathic growth hormone deficiency during 12 months of growth hormone treatment.
    Ciresi A; Amato MC; Giordano C
    J Endocrinol Invest; 2015 Mar; 38(3):351-9. PubMed ID: 25273336
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Individualized low-dose growth hormone (GH) treatment in GH-deficient adults with childhood-onset disease: metabolic effects during fasting and hypoglycemia.
    Bülow B; Agardh CD; Eckert B; Erfurth EM
    Metabolism; 1999 Aug; 48(8):1003-10. PubMed ID: 10459565
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Utility of C-peptide for a reliable estimate of insulin secretion in children with growth hormone deficiency.
    Ciresi A; Cicciò F; Radellini S; Giordano C
    Growth Horm IGF Res; 2016 Aug; 29():71-77. PubMed ID: 27235725
    [TBL] [Abstract][Full Text] [Related]  

  • 45. One-year GH replacement therapy reduces early cardiac target organ damage (TOD) in adult GHD patients.
    Boschetti M; Agosti S; Albanese V; Casalino L; Teti C; Bezante GP; Brunelli C; Albertelli M; Ferone D
    Endocrine; 2017 Feb; 55(2):573-581. PubMed ID: 27075720
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Administration of acylated ghrelin reduces insulin sensitivity, whereas the combination of acylated plus unacylated ghrelin strongly improves insulin sensitivity.
    Gauna C; Meyler FM; Janssen JA; Delhanty PJ; Abribat T; van Koetsveld P; Hofland LJ; Broglio F; Ghigo E; van der Lely AJ
    J Clin Endocrinol Metab; 2004 Oct; 89(10):5035-42. PubMed ID: 15472202
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cardiovascular risk of young growth-hormone-deficient adolescents. Differences in growth-hormone-treated and untreated patients.
    Lanes R; Paoli M; Carrillo E; Villaroel O; Palacios A
    Horm Res; 2003; 60(6):291-6. PubMed ID: 14646407
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Do all adults with growth hormone deficiency require growth hormone treatment?
    Brooke AM; Monson JP
    Ann Med; 2003; 35(6):419-24. PubMed ID: 14572166
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of growth hormone therapy on metabolic parameters, adipokine and endothelial dysfunction in prepuberal children.
    Cañete MD; Valle-Martos R; Martos R; Cañete R; Valle M; Jiménez-Reina L
    Acta Paediatr; 2019 Nov; 108(11):2027-2033. PubMed ID: 31087421
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Untreated growth hormone deficiency explains premature mortality in patients with hypopituitarism.
    Bengtsson BA
    Growth Horm IGF Res; 1998 Feb; 8 Suppl A():77-80. PubMed ID: 10993596
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Autonomic nervous system and cardiovascular risk assessment during one year of growth hormone replacement therapy in adults with growth hormone deficiency.
    Boschetti M; Casu M; Moretti S; Teti C; Albanese V; Albertelli M; Murialdo G; Minuto F; Ferone D
    Hormones (Athens); 2015; 14(1):134-41. PubMed ID: 25402370
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Suppression in growth hormone during overeating ameliorates the increase in insulin resistance and cardiovascular disease risk.
    Cornford AS; Barkan AL; Hinko A; Horowitz JF
    Am J Physiol Endocrinol Metab; 2012 Nov; 303(10):E1264-72. PubMed ID: 23011065
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of aerobic exercise on ectopic lipids in patients with growth hormone deficiency before and after growth hormone replacement therapy.
    Christ ER; Egger A; Allemann S; Buehler T; Kreis R; Boesch C
    Sci Rep; 2016 Jan; 6():19310. PubMed ID: 26792091
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Insulin resistance, metabolic syndrome and chronic low grade inflammation in Sheehan's syndrome on standard replacement therapy: a case control study.
    Bhat MA; Laway BA; Shah ZA; Wani AI; Mubarik I
    Pituitary; 2015 Jun; 18(3):312-8. PubMed ID: 24879499
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of hypopituitarism and growth hormone replacement therapy on the production and utilization of glucose in childhood.
    Bougneres PF; Artavia-Loria E; Ferre P; Chaussain JL; Job JC
    J Clin Endocrinol Metab; 1985 Dec; 61(6):1152-7. PubMed ID: 3902870
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Physiologic growth hormone replacement improves fasting lipid kinetics in patients with HIV lipodystrophy syndrome.
    D'Amico S; Shi J; Sekhar RV; Jahoor F; Ellis KJ; Rehman K; Willis J; Maldonado M; Balasubramanyam A
    Am J Clin Nutr; 2006 Jul; 84(1):204-11. PubMed ID: 16825697
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Growth hormone replacement therapy regulates microRNA-29a and targets involved in insulin resistance.
    Galimov A; Hartung A; Trepp R; Mader A; Flück M; Linke A; Blüher M; Christ E; Krützfeldt J
    J Mol Med (Berl); 2015 Dec; 93(12):1369-79. PubMed ID: 26199111
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Metabolic alterations in patients who develop traumatic brain injury (TBI)-induced hypopituitarism.
    Prodam F; Gasco V; Caputo M; Zavattaro M; Pagano L; Marzullo P; Belcastro S; Busti A; Perino C; Grottoli S; Ghigo E; Aimaretti G
    Growth Horm IGF Res; 2013 Aug; 23(4):109-13. PubMed ID: 23660372
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The increased insulin sensitivity in growth hormone-deficient adults is reduced by growth hormone replacement therapy.
    Riedl M; Ludvik B; Pacini G; Clodi M; Kotzmann H; Wagner O; Kautzky-Willer A; Prager R; Luger A
    Eur J Clin Invest; 2000 Sep; 30(9):771-8. PubMed ID: 10998076
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Hyperlipidemia in patients with GH deficiency].
    Hizuka N
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():167-71. PubMed ID: 11347051
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.